Ergothioneine supplement study for dialysis patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether giving a natural antioxidant called ergothioneine can help people with kidney failure who are on dialysis. It aims to see if it improves their health or well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have kidney failure and be receiving dialysis (hemodialysis or peritoneal dialysis).
- You must not have had a blood transfusion within the last 90 days.
- You must not be taking any supplements that contain ergothioneine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a supplement called CoQ10, along with supervised exercise, can improve how the body uses energy in people on chronic dialysis. It may help with muscle function and overall health if your heart and dialysis situation are stable enough.
This study tests whether a medication called erythropoietin (a hormone that helps your body make red blood cells) can improve hemoglobin levels in people on dialysis. It also looks at whether metabolic syndrome (a group of conditions like high blood pressure and high blood sugar) makes the medicine less effective.
This study tests whether taking a probiotic (a healthy bacteria supplement) can help people with kidney failure on dialysis respond better to erythropoietin, a medicine that treats anemia (low red blood cells). If the probiotic works, it could reduce the need for high doses of this medicine and improve your energy levels.
This study tests whether taking probiotics or synbiotics (supplements that support gut health) can improve nutritional status in people on regular hemodialysis. It may help you feel better and stay stronger if you are on dialysis.
This trial tests whether a special blend of probiotics and prebiotics (called a synbiotic) can improve gut health and reduce harmful waste products in the blood for people on hemodialysis.
This trial studies whether curcumin (the active ingredient in turmeric) can help reduce inflammation in people on dialysis. You may continue your regular kidney treatment while taking curcumin, and the study will check your blood for changes in inflammation markers.
Hear when a new ESRD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.